Impact of the COVID-19 Pandemic on Staging Oncologic PET/CT Imaging and Patient Outcome in a Public Healthcare Context: Overview and Follow Up of the First Two Years of the Pandemic DOI Open Access
Andrés Kohan,

Sumesh Menon,

Vanessa Murad

et al.

Cancers, Journal Year: 2023, Volume and Issue: 15(22), P. 5358 - 5358

Published: Nov. 10, 2023

To assess the impact of COVID-19 pandemic on diagnosis, staging and outcome a selected population throughout first two years pandemic, we evaluated oncology patients undergoing PET/CT at our institution. A retrospective lung cancer, melanoma, lymphoma head neck cancer staged using during 6 months 2019, 2020 2021 were included for analysis. The year in which PET was performed exposure variable, main outcomes stage time overall survival (OS). total 1572 PET/CTs purposes 2021. median age 66 (IQR 16), 915 (58%) males. most prevalent (643, 41%). univariate analysis OS by not significantly different. multivariate Cox regression non-COVID-19 different variables determined that (HR 1.76 CI95 1.23-2.53, p < 0.05), III 3.63 2.21-5.98, IV 11.06 7.04-17.36, 0.05) diagnosis 1.04 1.02-1.05, had increased risks death. We did find higher stages or reduced when assessing performed. Furthermore, modified staged, even controlled significant (age, type gender).

Language: Английский

Head and neck cancer diagnoses and faster treatment initiation during COVID-19: Correspondence DOI Open Access
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit

Radiotherapy and Oncology, Journal Year: 2022, Volume and Issue: 169, P. 145 - 145

Published: Jan. 29, 2022

Language: Английский

Citations

1
Impact of COVID-19 on head and neck mucosal squamous cell carcinoma: Correspondence DOI
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit

American Journal of Otolaryngology, Journal Year: 2022, Volume and Issue: 43(3), P. 103392 - 103392

Published: Feb. 8, 2022

Language: Английский

Citations

1
Title: Impact of the COVID-19 pandemic on the severity of newly diagnosed cases of head and neck squamous cell carcinoma in southern Brazil DOI Creative Commons
Kívia Linhares Ferrazzo, Cristiane Cademartori Danesi, Nara Maria Beck Martins

et al.

Research Square (Research Square), Journal Year: 2023, Volume and Issue: unknown

Published: Jan. 10, 2023

Abstract Purpose Responsible for more than 360 thousand deaths in the world, head and neck squamous cell carcinoma (HNSCC) is an important public health problem worldwide, being prevalent men, smokers alcoholics, aged over 40 years with lower socioeconomic status. Some of these risk factors are also common to increased developing severe cases COVID-19, pandemic that has been affecting world since beginning 2020. The aim this study was retrospectively assess impact COVID-19 on HNSCC diagnosis severity disease a hospital southern Brazil. Methods All new diagnosed from March 11, 2019 10, 2020 (pre-COVID-19 group) all 2010 2021 (COVID-19 were included. Data obtained through histopathological reports medical records. Results There no difference number diagnoses group (n = 45) compared pre-COVID-19 47). Patients' sociodemographic profile, time between treatment, overall TNM staging similar. However, clinical N classification (p 0.021). Patients during 4.05 times likely have lymph node involvement (95% CI:1.62–10.12). Conclusion Although there reduction period greater restriction pandemic, showed metastasis advanced stages.

Language: Английский

Citations

0
COVID-19 impact on the management of head and neck cancer: a French single-centre experience DOI
Clémentine Maheo,

Clement Camille,

Archimede Swann

et al.

European Archives of Oto-Rhino-Laryngology, Journal Year: 2023, Volume and Issue: 281(2), P. 873 - 882

Published: Oct. 16, 2023

Language: Английский

Citations

0
Impact of the COVID-19 Pandemic on Staging Oncologic PET/CT Imaging and Patient Outcome in a Public Healthcare Context: Overview and Follow Up of the First Two Years of the Pandemic DOI Open Access
Andrés Kohan,

Sumesh Menon,

Vanessa Murad

et al.

Cancers, Journal Year: 2023, Volume and Issue: 15(22), P. 5358 - 5358

Published: Nov. 10, 2023

To assess the impact of COVID-19 pandemic on diagnosis, staging and outcome a selected population throughout first two years pandemic, we evaluated oncology patients undergoing PET/CT at our institution. A retrospective lung cancer, melanoma, lymphoma head neck cancer staged using during 6 months 2019, 2020 2021 were included for analysis. The year in which PET was performed exposure variable, main outcomes stage time overall survival (OS). total 1572 PET/CTs purposes 2021. median age 66 (IQR 16), 915 (58%) males. most prevalent (643, 41%). univariate analysis OS by not significantly different. multivariate Cox regression non-COVID-19 different variables determined that (HR 1.76 CI95 1.23-2.53, p < 0.05), III 3.63 2.21-5.98, IV 11.06 7.04-17.36, 0.05) diagnosis 1.04 1.02-1.05, had increased risks death. We did find higher stages or reduced when assessing performed. Furthermore, modified staged, even controlled significant (age, type gender).

Language: Английский

Citations

0